These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8039476)

  • 21. High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients.
    Wilson EA; Sills GJ; Forrest G; Brodie MJ
    Epilepsy Res; 1998 Jan; 29(2):161-6. PubMed ID: 9477149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy.
    Schumacher TB; Beck H; Steinhäuser C; Schramm J; Elger CE
    Epilepsia; 1998 Apr; 39(4):355-63. PubMed ID: 9578025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures.
    Ben-Menachem E; Söderfelt B; Hamberger A; Hedner T; Persson LI
    Epilepsy Res; 1995 Jul; 21(3):231-6. PubMed ID: 8536677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
    Harden CL; Lazar LM; Pick LH; Nikolov B; Goldstein MA; Carson D; Ravdin LD; Kocsis JH; Labar DR
    Epilepsia; 1999 Aug; 40(8):1129-34. PubMed ID: 10448827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.
    Borowicz KK; Swiader M; Luszczki J; Czuczwar SJ
    Epilepsia; 2002 Sep; 43(9):956-63. PubMed ID: 12199720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gabapentin (Neurontin): a new possibility in the add-on therapy of partial epilepsies].
    Krämer G
    Praxis (Bern 1994); 1996 Jan; 85(4):84-93. PubMed ID: 8578059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study.
    Mattia D; Spanedda F; Bassetti MA; Romigi A; Placidi F; Marciani MG
    Clin Neurophysiol; 2000 Feb; 111(2):311-7. PubMed ID: 10680567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
    Bergey GK; Morris HH; Rosenfeld W; Blume WT; Penovich PE; Morrell MJ; Leiderman DB; Crockatt JG; LaMoreaux L; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
    Herranz JL; Sol JM; Hernández G
    Rev Neurol; 2000 Jun 16-30; 30(12):1141-5. PubMed ID: 10935239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind study of Gabapentin in the treatment of partial seizures.
    Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P
    Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gabapentin.
    Bruni J
    Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S10-2. PubMed ID: 8951214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
    Morrell MJ; McLean MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus L; Bernstein P; Rose-Legatt
    Seizure; 2000 Jun; 9(4):241-8. PubMed ID: 10880282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
    Beran R; Berkovic S; Black A; Danta G; Dunne J; Frasca J; Grainger K; Kilpatrick C; McKenzie R; McLaughlin D; Schapel G; Somerville E
    Epilepsia; 2001 Oct; 42(10):1335-9. PubMed ID: 11737169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gabapentin for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of gabapentin with other antiepileptic and GABAergic drugs.
    Kondo T; Fromm GH; Schmidt B
    Epilepsy Res; 1991 Apr; 8(3):226-31. PubMed ID: 1868822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the pharmacotherapy of epilepsy.
    Ramsay RE
    Epilepsia; 1993; 34 Suppl 5():S9-16. PubMed ID: 8339715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gabapentin toxicity in children manifesting as behavioral changes.
    Wolf SM; Shinnar S; Kang H; Gil KB; Moshé SL
    Epilepsia; 1995 Dec; 36(12):1203-5. PubMed ID: 7489697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: experience in the United States with three novel drugs.
    French JA
    Epilepsia; 1996; 37 Suppl 2():S23-S26. PubMed ID: 8641243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.